AKT1 and cancer: In pancreatic cancer cells, the COL11A1/Akt axis disrupts the balance between BAX and BCL-2, and inhibits the release of cytochrome C, thereby destroying mitochondrial function and promoting apoptosis escape in turn leading to drug resistance in these cancer cells.